<DOC>
	<DOC>NCT00004422</DOC>
	<brief_summary>OBJECTIVES: Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the treatment of severe pertussis in children.</brief_summary>
	<brief_title>Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection</brief_title>
	<detailed_description>PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive an infusion of either pertussis immune globulin or placebo (0.9% saline). Patients are followed every 2 weeks for up to 6 months. Completion date provided represents the completion date of the grant per OOPD records</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins, Intravenous</mesh_term>
	<mesh_term>Rho(D) Immune Globulin</mesh_term>
	<criteria>Documented infection with Bordetella pertussis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>June 2000</verification_date>
	<keyword>bacterial infection</keyword>
	<keyword>immunologic disorders and infectious disorders</keyword>
	<keyword>pertussis</keyword>
	<keyword>rare disease</keyword>
</DOC>